Nureca Buyback Greenlit: ₹191.4 Crore Proposal Approved to Boost Shareholder Value

Buyback Approval Details

Nureca Limited , known for brands like Dr Trust and Dr Physio in home healthcare and wellness, approved the buyback proposal at its board meeting on November 28, 2025. This follows SEBI's nod for an exemption from buyback regulations during its internal merger with Nureca Technologies Private Limited, ensuring no change in shareholding. Promoters opted out, reserving the opportunity for public investors to tender shares.​

Strategic Context

The buyback aims to optimize capital structure, enhance earnings per share, and return value amid steady sector demand. Shares hit a 5% upper circuit at ₹267.5 post-announcement buzz, reflecting market optimism despite past sales challenges. Trading window closed from November 26 to December 2 for compliance.​

Key Highlights

Buyback Size: Up to ₹191.4 million (₹19.14 crore) via open market or tender process.

Eligibility: Exclusive to public shareholders; promoters abstain.

Regulatory Nod: SEBI exemption granted October 2025 for merger overlap.

Share Impact: Pre-buyback pattern detailed; potential EPS uplift.

Next Steps: Shareholder approval, record date, and execution timeline to follow.

Sources: NSE India filings, Business Standard, SEBI order.